Shopping Cart 0
Cart Subtotal
AED 0

Nexstim Plc (NXTMH) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258

Details

Summary

Nexstim Plc (Nexstim), a medical technology company that develops, manufactures and commercializes non-invasive brain stimulation technologies and devices to treat patients suffering from depressive disorders and chronic pain. The company provides Navigated Brain Therapy (NBT) system for the treatment of major depression disorder (MDD) and chronic neuropathic pain and Navigated Brain Stimulation (NBS) system for pre-surgical diagnostics. It develops products based on its proprietary SmartFocus TMS technology. Nexstim offers its products primarily to leading hospitals and universities through direct sales and distributors in the US, Europe, and Asia. The company operates in Finland, Germany and the US. Nexstim is headquartered in Helsinki, Finland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Nexstim Plc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Nexstim Plc Company Overview

Nexstim Plc Company Snapshot

Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview

Nexstim Plc-Pipeline Analysis Overview

Business Description

Nexstim Plc-Key Facts

Nexstim Plc-Major Products and Services

Nexstim Plc Pipeline Products by Development Stage

Nexstim Plc Pipeline Products Overview

Navigated Brain Therapy System-Chronic Neuropathic Pain

Navigated Brain Therapy System-Chronic Neuropathic Pain Product Overview

Navigated Brain Therapy System-Chronic Spinal Cord Injury

Navigated Brain Therapy System-Chronic Spinal Cord Injury Product Overview

Navigated Brain Therapy System-Major Depressive Disorder

Navigated Brain Therapy System-Major Depressive Disorder Product Overview

Navigated Brain Therapy System-Stroke Rehabilitation

Navigated Brain Therapy System-Stroke Rehabilitation Product Overview

Navigated Brain Therapy System-Tinnitus

Navigated Brain Therapy System-Tinnitus Product Overview

Navigational Brain Stimulation (NBS) System 4

Navigational Brain Stimulation (NBS) System 4 Product Overview

Wireless EMG Integrated NBS System

Wireless EMG Integrated NBS System Product Overview

Nexstim Plc-Key Competitors

Nexstim Plc-Key Employees

Nexstim Plc-Key Employee Biographies

Nexstim Plc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Nexstim Plc, Recent Developments

Jul 03, 2019: Second Nexstim NBT system ordered by Island Psychiatry PC, US

Jun 18, 2019: Leading Austrian Clinic, Klinik Pirawarth, provides positive feedback on its first Nexstim NBT system for treatment of depression and pain

May 28, 2019: Nexstim NBS system sold to the Jewish General Hospital in Canada

May 22, 2019: Nexstim sells first NBT system in Germany for depression therapy and research

May 10, 2019: Nexstim enters depression therapy market in Sweden

Apr 24, 2019: Nexstim names Professor Paul Fitzgerald to Scientific Advisory Board

Apr 10, 2019: Professor Alvaro Pascual-Leone joins Nexstim scientific advisory board

Apr 05, 2019: Professor Linda Carpenter joins Nexstim's Scientific Advisory Board

Apr 02, 2019: Nexstim has prepared a supplement to the prospectus.

Mar 29, 2019: Health Canada grants Nexstim NBS system and NexSpeech medical device license for Canada

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Nexstim Plc Pipeline Products by Equipment Type

Nexstim Plc Pipeline Products by Development Stage


List Of Table

List of Tables

Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview

Nexstim Plc Pipeline Products by Equipment Type

Nexstim Plc Pipeline Products by Indication

Nexstim Plc, Key Facts

Nexstim Plc, Major Products and Services

Nexstim Plc Number of Pipeline Products by Development Stage

Nexstim Plc Pipeline Products Summary by Development Stage

Navigated Brain Therapy System-Chronic Neuropathic Pain-Product Status

Navigated Brain Therapy System-Chronic Neuropathic Pain-Product Description

Navigated Brain Therapy System-Chronic Spinal Cord Injury-Product Status

Navigated Brain Therapy System-Chronic Spinal Cord Injury-Product Description

Navigated Brain Therapy System-Major Depressive Disorder-Product Status

Navigated Brain Therapy System-Major Depressive Disorder-Product Description

Navigated Brain Therapy System-Stroke Rehabilitation-Product Status

Navigated Brain Therapy System-Stroke Rehabilitation-Product Description

Navigated Brain Therapy System-Tinnitus-Product Status

Navigated Brain Therapy System-Tinnitus-Product Description

Navigational Brain Stimulation (NBS) System 4-Product Status

Navigational Brain Stimulation (NBS) System 4-Product Description

Wireless EMG Integrated NBS System-Product Status

Wireless EMG Integrated NBS System-Product Description

Nexstim Plc, Key Employees

Nexstim Plc, Key Employee Biographies

Nexstim Plc, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Nexstim Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Stryker Corp

MicroVention Inc

Medtronic Plc

Lumenis Ltd

Integra LifeSciences Holdings Corp

Aesculap AG

Company Profile

Company Profile Title

Summary

Nexstim Plc (Nexstim), a medical technology company that develops, manufactures and commercializes non-invasive brain stimulation technologies and devices to treat patients suffering from depressive disorders and chronic pain. The company provides Navigated Brain Therapy (NBT) system for the treatment of major depression disorder (MDD) and chronic neuropathic pain and Navigated Brain Stimulation (NBS) system for pre-surgical diagnostics. It develops products based on its proprietary SmartFocus TMS technology. Nexstim offers its products primarily to leading hospitals and universities through direct sales and distributors in the US, Europe, and Asia. The company operates in Finland, Germany and the US. Nexstim is headquartered in Helsinki, Finland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Nexstim Plc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Nexstim Plc Company Overview

Nexstim Plc Company Snapshot

Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview

Nexstim Plc-Pipeline Analysis Overview

Business Description

Nexstim Plc-Key Facts

Nexstim Plc-Major Products and Services

Nexstim Plc Pipeline Products by Development Stage

Nexstim Plc Pipeline Products Overview

Navigated Brain Therapy System-Chronic Neuropathic Pain

Navigated Brain Therapy System-Chronic Neuropathic Pain Product Overview

Navigated Brain Therapy System-Chronic Spinal Cord Injury

Navigated Brain Therapy System-Chronic Spinal Cord Injury Product Overview

Navigated Brain Therapy System-Major Depressive Disorder

Navigated Brain Therapy System-Major Depressive Disorder Product Overview

Navigated Brain Therapy System-Stroke Rehabilitation

Navigated Brain Therapy System-Stroke Rehabilitation Product Overview

Navigated Brain Therapy System-Tinnitus

Navigated Brain Therapy System-Tinnitus Product Overview

Navigational Brain Stimulation (NBS) System 4

Navigational Brain Stimulation (NBS) System 4 Product Overview

Wireless EMG Integrated NBS System

Wireless EMG Integrated NBS System Product Overview

Nexstim Plc-Key Competitors

Nexstim Plc-Key Employees

Nexstim Plc-Key Employee Biographies

Nexstim Plc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Nexstim Plc, Recent Developments

Jul 03, 2019: Second Nexstim NBT system ordered by Island Psychiatry PC, US

Jun 18, 2019: Leading Austrian Clinic, Klinik Pirawarth, provides positive feedback on its first Nexstim NBT system for treatment of depression and pain

May 28, 2019: Nexstim NBS system sold to the Jewish General Hospital in Canada

May 22, 2019: Nexstim sells first NBT system in Germany for depression therapy and research

May 10, 2019: Nexstim enters depression therapy market in Sweden

Apr 24, 2019: Nexstim names Professor Paul Fitzgerald to Scientific Advisory Board

Apr 10, 2019: Professor Alvaro Pascual-Leone joins Nexstim scientific advisory board

Apr 05, 2019: Professor Linda Carpenter joins Nexstim's Scientific Advisory Board

Apr 02, 2019: Nexstim has prepared a supplement to the prospectus.

Mar 29, 2019: Health Canada grants Nexstim NBS system and NexSpeech medical device license for Canada

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Nexstim Plc Pipeline Products by Equipment Type

Nexstim Plc Pipeline Products by Development Stage


List Of Table

List of Tables

Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview

Nexstim Plc Pipeline Products by Equipment Type

Nexstim Plc Pipeline Products by Indication

Nexstim Plc, Key Facts

Nexstim Plc, Major Products and Services

Nexstim Plc Number of Pipeline Products by Development Stage

Nexstim Plc Pipeline Products Summary by Development Stage

Navigated Brain Therapy System-Chronic Neuropathic Pain-Product Status

Navigated Brain Therapy System-Chronic Neuropathic Pain-Product Description

Navigated Brain Therapy System-Chronic Spinal Cord Injury-Product Status

Navigated Brain Therapy System-Chronic Spinal Cord Injury-Product Description

Navigated Brain Therapy System-Major Depressive Disorder-Product Status

Navigated Brain Therapy System-Major Depressive Disorder-Product Description

Navigated Brain Therapy System-Stroke Rehabilitation-Product Status

Navigated Brain Therapy System-Stroke Rehabilitation-Product Description

Navigated Brain Therapy System-Tinnitus-Product Status

Navigated Brain Therapy System-Tinnitus-Product Description

Navigational Brain Stimulation (NBS) System 4-Product Status

Navigational Brain Stimulation (NBS) System 4-Product Description

Wireless EMG Integrated NBS System-Product Status

Wireless EMG Integrated NBS System-Product Description

Nexstim Plc, Key Employees

Nexstim Plc, Key Employee Biographies

Nexstim Plc, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Nexstim Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Stryker Corp

MicroVention Inc

Medtronic Plc

Lumenis Ltd

Integra LifeSciences Holdings Corp

Aesculap AG